ClinTrial Research (CTR) announces that it has closed a growth equity round led by Tarsadia Investments, a multi-billion-dollar firm that makes high-conviction investments in category-defining companies globally. The investment reflects Tarsadia’s conviction that CTR is positioned to become the leader in the clinical site network sector. “We fully believe in CTR’s mission to build the industry’s most trusted clinical site network—one that brings together exceptional people, advanced technology, and strong therapeutic leadership to elevate patient care and drive lasting innovation,” said Rishi Reddy, Managing Director and Head of Venture and Growth Equity at Tarsadia.
Read the full article: ClinTrial Research and Tarsadia Investments Partner to Build Next Generation Site Network //
Source: https://www.prnewswire.com/news-releases/clintrial-research-and-tarsadia-investments-partner-to-build-next-generation-site-network-302644934.html